Archive for the ‘Lyme’ Category

The Secret History of Lyme Disease the US Government Doesn’t Want You to Know

The secret history of Lyme disease the US government doesn’t want you to know | Unreported

Jun 17, 2026 Unreported with Meagan Medick

Nearly half a million Americans are diagnosed with Lyme disease every year, and ER tick bite visits are hitting the highest levels since 2017. So why does it feel like nobody is sounding the alarm? And why is Congress now ordering a federal watchdog to dig through decades of classified Cold War military records searching for answers?

In this episode of “Unreported,” Meagan Medick sits down with author Kris Newby, who wrote “Bitten: The Secret History of Lyme Disease and Biological Weapons” and is a senior producer on the Oscar semi-finalist documentary “Under Our Skin.” Together, they examine documented evidence that the U.S. government experimented on ticks as potential Cold War bioweapons, the whistleblower testimony of the scientist who discovered Lyme disease and why a mystery organism he identified in the original ticks was quietly removed from his discovery paper.

They also dig into the Lone Star tick experiments that may have seeded the Northeast with nonnative species, the rise of meat allergies and why a new Lyme vaccine is already raising red flags. Plus: what the Cold War records investigation in Congress could uncover and who controls what gets released.

For more:

Category:

Activism, Lyme, Ticks, Transmission

Vineyard Gazette: Scientists Study Martha’s Vineyard to Get to Root of Chronic Lyme

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/34959511

Vinyard Gazette: Scientists Study Martha’s Vineyard to Get to Root of Chronic Lyme

Carl TuttleHudson, NH, United States

Jul 13, 2026

God forbid we find better antimicrobials for treating Lyme disease because that would give the public an excuse not to take the Lyme vaccine soon to be released!!!

—– Forwarded Message —–
From: CARL TUTTLE <runagain@comcast.net>
To: egenter@vineyardgazette.com <egenter@vineyardgazette.com>; bill@vineyardgazette.com <bill@vineyardgazette.com>; news@vineyardgazette.com <news@vineyardgazette.com>
Cc: linden.hu@tufts.edu <linden.hu@tufts.edu>; cseguin@partners.org <cseguin@partners.org>; jayanta.bhattacharya@nih.hhs.gov <jayanta.bhattacharya@nih.hhs.gov>; Stephanie.Haridopolos@hhs.gov <stephanie.haridopolos@hhs.gov>; kalachakra108@aol.com <kalachakra108@aol.com>; kbliegnermd@optonline.net <kbliegnermd@optonline.net>
Sent: Tuesday, June 30, 2026 at 02:26:37 PM EDT
Subject: Vinyard Gazette: Scientists Study Martha’s Vineyard to Get to Root of Chronic Lyme

Vinyard Gazette
Scientists Study Martha’s Vineyard to Get to Root of Chronic Lyme
https://vineyardgazette.com/news/2026/06/28/scientists-study-marthas-vineyard-get-root-chronic-lyme
By Ethan Genter June 28, 2026

Excerpt:
“We don’t really have any idea,” said Dr. Linden Hu, an infectious disease specialist at Tufts who is helping lead the research. “We had the same hypotheses we had 30 years ago with no clear .
“People are recruited when they have the tell-tale rash – one of the earliest signs of Lyme disease.”

Vineyard Gazette
Edgartown, MA
Attn: Ethan Genter, News Editor

Dear Ethan,
Please see the following eleven articles published in the peer-reviewed literature on dapsone combination therapy for Lyme disease and the MSIDS model. Does Dr. Hu really not know about them, or dismisses Dr. Horowitz’ results because it’s not based on a randomized trial? It is interesting that Tufts received millions of dollars of research money from the NIH and Horowitz couldn’t get a 250k grant approved for a randomized, multicenter trial. More on that found here:

Dr. Jay Bhattacharya; Fund Dr. Richard Horowitz’ R34 NIH grant on Dapsone treatment for Lyme disease
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/34365550

As for Hu’s research, it is focusing on the acute or early stage of the disease while patients who are the sickest went years or decades before obtaining a diagnosis ignoring the late-stage Lyme epidemic seen all across this nation. What academic discipline would Hu encounter if he focused on better antimicrobials???
11 Dapsone Articles on The Effective Treatment of Chronic LD & Associated Co-infections Including Bartonella: As of April 2026
Horowitz, R. Improving biomarkers of inflammation including phosphorylated tau in a patient with chronic Lyme disease/post-treatment Lyme disease syndrome using dapsone combination therapy: A case study and literature review. Journal of Alzheimer’s Disease Reports. April 27, 2026. DOI: 10.1177/25424823261445434 https://journals.sagepub.com/…/10.1177/25424823261445434
Horowitz, R.I.; Fallon, J.; Freeman, P.R. Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review. Microorganisms 2024, 12, 909. https://doi.org/10.3390/microorganisms12050909
Horowitz, R.I.; Fallon, J.; Freeman, P.R. Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections. Microorganisms 2023, 11, 2301. https://doi.org/10.3390/microorganisms11092301
Horowitz RI, Freeman PR. Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review. Antibiotics. 2022; 11(7):912. https://doi.org/10.3390/antibiotics11070912
https://www.mdpi.com/2079-6382/11/7/912/htm
Horowitz, R.I.; Freeman, P.R. Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review. Antibiotics 2020, 9, 725. https://doi.org/10.3390/antibiotics9110725
Horowitz, R.I., Murali, K., Gaur, G. et al. Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi. BMC Res Notes 13, 455 (2020). https://doi.org/10.1186/s13104-020-05298-6
https://bmcresnotes.biomedcentral.com/…/s13104-020
Horowitz, R.I.; Freeman, P.R. Precision Medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1. International Journal of General Medicine 2019:12 101–119
https://www.dovepress.com/precision-medicine
https://www.ncbi.nlm.nih.gov/pubmed/30863136
https://www.ncbi.nlm.nih.gov/pubmed/30863136
Horowitz, R.I.; Freeman, P.R. Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2. Healthcare 2018, 6, 129.
https://www.ncbi.nlm.nih.gov/pubmed/30400667
Horowitz RI, Freeman PR (2016) Are Mycobacterium Drugs Effective for Treatment Resistant Lyme Disease, Tick-Borne Co-Infections, and Autoimmune Disease?. JSM Arthritis 1(2): 1008.
Horowitz RI, Freeman PR (2016) The Use of Dapsone as a Novel “Persister” Drug in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome. J Clin Exp Dermatol Res 7: 345. doi:10.4172/2155-9554.1000345
Tardo AC, McDaniel CE and Embers ME (2023). Superior efficacy of combination antibiotic therapy versus monotherapy in a mouse model of Lyme disease. Front. Microbiol. 14:1293300. doi: 10.3389/fmicb.2023.1293300
https://www.frontiersin.org/…/fmicb.2023.1293300/full
Dapsone documentary 2024:
https://drtalks.com/…/discover-healing-18-dapsone…/
Dapsone documentary 2025:
https://drtalks.com/…/dapsone-documentary-9-stories-of
Dr. H Podcast with Dr Alain Mass and Dr Charlie Bizilj on The Success of Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease. May 21, 2025
https://us06web.zoom.us/…/TSVaYe6azIti
Passcode: &0yqten0
Dr. Horowitz has a new book and website, which has the 2000+ scientific references in Ending Chronic Illness listed on the site for review.
https://cangetbetter.com/

Respectfully Submitted,
Carl Tuttle
Independent Researcher
Hudson, NH
Cc:
-Dr. Linden Hu, Professor of Immunology at Tufts Medical School
-Claire Seguin, DNP, President and Chief Operating Officer of Martha’s Vineyard Hospital
-Bill Eville, Editor Vinyard Gazette
-Stephanie E. Haridopolos, MD, DABFM Principal Deputy Assistant Secretary for Health
-Jay Bhattacharya, Director of the National Institutes of Health
-Dr. Richard Horowitz, MD Board certified internist in private practice in Hyde Park, New York
-Dr. Kenneth B. Liegner Board Certified Internist with additional training in Pathology and Critical Care Medicine, practicing in Pawling, New York.
Paralyzed by Lyme, they were helped with combo treatments (please read!!!)
https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/31772769

Sign this petition

Category:

Activism, Lyme, research, Treatment, vaccines

Why You Still Feel Sick After Standard Lyme Treatment

Why You Still Feel Sick After Standard Lyme Treatment

Dr. Jaquel Patterson

June 10, 2026

Lyme disease rarely travels alone, and unaddressed co-infections like Bartonella, Babesia, Ehrlichia, Anaplasma, Mycoplasma, and Rickettsia are some of the most common reasons chronic Lyme patients don’t recover. In this video, I walk through how each co-infection is distinct, why standard Lyme antibiotics don’t cover them, and what a truly comprehensive testing and treatment approach should look like. Learn more: https://www.fairfieldfamilyhealth.com

CHAPTERS

00:00 Why Lyme Treatment Often Isn’t Enough

01:32 What Tick Borne Co-Infections Actually Are

02:54 Bartonella, Babesia, and Why They Get Missed

06:55 Why Standard Lyme Testing Fails to Catch Co-Infections

08:46 The Clinical Patterns That Point to Hidden Infections

09:55 What Comprehensive Tick Borne Testing Looks Like

11:37 Treatment Protocols for Each Co-Infection

14:29 Final Takeaways for Chronic Lyme Patients

________________

**Comment**

And this, right here, is why many patients are not better and never get better. Further, testing absolutely sucks. ALL of it. Pathogens working together create a severe clinical picture. Many of these pathogens require completely different medications. Mainstream doctors are clueless on all of this and have furthered an antiquated, unscientific case definition and treatment protocol for over 40 years.

It is far, far more complex than most doctors are aware. They spend very little time studying this in med school and what they do study is completely wrong.

For more:

Category:

Activism, Lyme, Testing, Treatment

There’s a New Type of Lyme Disease in NY. OY.

https://medicaldetective.substack.com/p/theres-a-new-type-of-lyme-disease-in-new-york-state-oy

There’s A New Type of Lyme disease in New York State. Oy.

Richard Horowitz

Jun 10, 2026

There are very few headlines that catch my eye. This one was surprising but not unexpected, since ticks are known to spread via travel on birds (and air travel has become more expensive these days, as I just found out after booking several flights). Here is the news release that made me pay more attention:

https://www.nbcnews.com/health/health-news/lyme-disease-rare-type-found-first-time-new-york-symptoms-severe-rcna348491

So what exactly is the ‘new type of Lyme disease (LD)’? It’s a strain of LD that is not normally found in NY State. Its Borrelia mayonii. The CDC just reported on it in their MMWR report. Here is a brief summary:

[From: Nafiz TN, Prusinski MA, Gubbala S, et al. Notes from the Field: Borrelia mayonii Lyme Disease — New York, 2025. MMWR Morb Mortal Wkly Rep 2026;75:271–272. DOI: http://dx.doi.org/10.15585/mmwr.mm7521a2]

This is an important case study, because B. mayonii clinically presents differently than an infection with Borrelia burgdorferi (Bb), so we need to understand how to properly diagnose and treat it if it is being found in new areas. (See link for article)

________________

**Comment**

Dr. Horowitz points out that the rash with B. mayonii is not the ‘classic’ rash seen with Bb, which isn’t so classic either, and highly variable – although it’s completely diagnostic, proving infection – no testing even required. If you have the rash, you are infected, period.

But there is concern for more severe systemic illness with B. mayonii due to a high level of spirochetes in the blood.

For more:

Category:

Lyme, research, Ticks, Transmission, Treatment

Seroprevalence of Borrelia, Anaplasma, Bartonella, Toxoplasma, Mycoplasma, Yersinia, and Chlamydia in Human Population From Eastern Poland

https://www.mdpi.com/2076-0817/14/1/96

Seroprevalence of Borrelia, Anaplasma, Bartonella,  Toxoplasma, Mycoplasma, Yersinia, and Chlamydia in Human Population from Eastern Poland

by Angelina Wójcik-Fatla 1, Anna Sawczyn-Domańska 1,*, Anna Kloc 1,Joanna Krzowska-Firych 2 and Jacek Sroka 1,3

*Author to whom correspondence should be addressed.

Pathogens 2025, 14(1), 96; https://doi.org/10.3390/pathogens14010096

Submission received: 3 December 2024 / Revised: 15 January 2025 / Accepted: 16 January 2025 / Published: 18 January 2025

(This article belongs to the Special Issue Exploring the Biodiversity of Parasites in Humans, Wild and Domestic Animals)

Abstract

The epidemiological situation related to infectious diseases is influenced by many factors. To monitor actual trends in selected zoonoses, a total of 473 serum samples from farmers, forestry workers, and veterinarians were collected for serological examination. Anti-Borrelia burgdorferi sensu lato (s.l.) antibodies were tested with ELISA and Western blot (WB) tests; the detection of anti-Toxoplasma gondii antibodies was performed using an enzyme linked fluorescence assay (ELFA). Antibodies to bartonellosis, anaplasmosis, and chlamydiosis were determined by indirect immunofluorescent test (IFA), whereas antibodies to yersiniosis and mycoplasmosis were confirmed in the ELISA test.

Positive or borderline results of antibodies against B. burgdorferi s.l. in the ELISA test were detected in 33.8% of the study population. The borderline or positive ELISA test results for at least one antibody class were confirmed by WB in 58.7% of cases. The IgG antibodies against Anaplasma phagocytophilum, Toxoplasma gondii, and Mycoplasma pneumoniae were detected in 9.6%, 51.7%, and 63.6% of samples, respectively. Antibodies against Yersinia spp., Bartonella henselae, and Chlamydia pneumoniae were found to vary between 43 and 47%.

Category:

Anaplasmosis, Bartonella, Lyme, Mycoplasma, research, Testing, Toxoplasmosis